We further performed BGS to detect the methylation of individual CpG sites on the HIC2 promoter of four glioma cell lines, and the results showed that HIC2 was highly methylated in four glioma cell lines (Figure S2D). This evidence concerns the gene HIC2 and central nervous system cancer.